Apontis Pharma AG (APPH) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.061x

Based on the latest financial reports, Apontis Pharma AG (APPH) has a cash flow conversion efficiency ratio of -0.061x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.94 Million ≈ $-2.27 Million USD) by net assets (€31.62 Million ≈ $36.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Apontis Pharma AG market capitalisation for the company's overall valuation and market capitalisation.

Apontis Pharma AG - Cash Flow Conversion Efficiency Trend (2019–2024)

This chart illustrates how Apontis Pharma AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Apontis Pharma AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Apontis Pharma AG ranked by their cash flow conversion efficiency. Explore how high is Apontis Pharma AG's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Zevia Pbc NYSE:ZVIA	0.003x
Intema Insaat ve Tesisat Malzemeleri Yatirim ve Pazarlama AS IS:INTEM	-0.034x
Welspun Investments and Commercials Limited NSE:WELINV	-0.002x
Bon Fame Co Ltd TWO:8433	0.008x
Qualicorp Consultoria e Corretora de Seguros S.A SA:QUAL3	-0.027x
Gan Ltd NASDAQ:GAN	-0.074x
Three A Resources Bhd KLSE:0012	0.049x
Ampire Co Ltd TWO:8049	0.048x

Annual Cash Flow Conversion Efficiency for Apontis Pharma AG (2019–2024)

The table below shows the annual cash flow conversion efficiency of Apontis Pharma AG from 2019 to 2024. View current stock price of Apontis Pharma AG for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€31.02 Million ≈ $36.26 Million	€-2.90 Million ≈ $-3.39 Million	-0.094x	+77.54%
2023-12-31	€30.26 Million ≈ $35.38 Million	€-12.60 Million ≈ $-14.73 Million	-0.416x	-257.05%
2022-12-31	€41.57 Million ≈ $48.60 Million	€11.02 Million ≈ $12.88 Million	0.265x	+214.37%
2021-12-31	€40.71 Million ≈ $47.60 Million	€3.43 Million ≈ $4.01 Million	0.084x	-79.90%
2020-12-31	€3.46 Million ≈ $4.04 Million	€1.45 Million ≈ $1.70 Million	0.420x	+917.97%
2019-12-31	€4.64 Million ≈ $5.43 Million	€-238.07K ≈ $-278.33K	-0.051x	--

About Apontis Pharma AG

XETRA:APPH Germany Drug Manufacturers - Specialty & Generic

Market Cap

$107.13 Million

€91.63 Million EUR

Market Cap Rank

#19606 Global

#1795 in Germany

Share Price

€11.00

Change (1 day)

+0.00%

52-Week Range

€10.75 - €11.05

All Time High

€26.90